2016
DOI: 10.1016/j.bmc.2016.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
29
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(30 citation statements)
references
References 22 publications
1
29
0
Order By: Relevance
“…(2) and (S)-N-[2-(2,6-dimethylphenoxy)ethyl]-1-hydroxypropan-2-aminium chloride (2c) were obtained as described previously (Waszkielewicz et al, 2015(Waszkielewicz et al, , 2016. Single crystals suitable for X-ray diffraction studies were recrystallized from a mixture of acetone and decane (1:1 v/v) for 1, and from isopropyl acetate for 2c by slow evaporation at room temperature.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…(2) and (S)-N-[2-(2,6-dimethylphenoxy)ethyl]-1-hydroxypropan-2-aminium chloride (2c) were obtained as described previously (Waszkielewicz et al, 2015(Waszkielewicz et al, , 2016. Single crystals suitable for X-ray diffraction studies were recrystallized from a mixture of acetone and decane (1:1 v/v) for 1, and from isopropyl acetate for 2c by slow evaporation at room temperature.…”
Section: Methodsmentioning
confidence: 99%
“…Reports on the anticonvulsant activity of the cardiovascular drugs propranolol (Fischer et al, 1985;Fischer, 2002) and mexiletine (Chew et al, 1979) prompted many scientists to search for other aminoalkanol and/or aroxyalkyl derivatives possessing similar properties and functions. For the last two decades, a group of aminoalkanol and aroxyalkyl derivatives have gained much attention due to their anticonvulsant activity (Marona et al, 2005;Pę kala et al, 2011;Waszkielewicz et al, 2013Waszkielewicz et al, , 2015Waszkielewicz et al, , 2016Pań czyk et al, 2018Pań czyk et al, , 2019. Research carried out by our team involved the crystal structure analysis of the tested compounds and an analysis of their anticonvulsant activity.…”
Section: Introductionmentioning
confidence: 99%
“…2-aminopropan-1-ol derivatives; Waszkielewicz et al, 2015) or for the preparation of crystals of other salts in order to study the structural properties of a compound in different environments (Ż esławska et al, 2018a). As a continuation of our medicinal chemistry and crystallographic studies of compounds showing anticonvulsant activity (Ż esławska et al, 2017, 2018b), we obtained further cyclic aminoalkanol derivatives, among which 1-[(2,3-dimethylphenoxy)ethyl]piperidin-4-ol hydrochloride is especially interesting, both from an activity and a chemical point of view (Waszkielewicz et al, 2016). Its activity was revealed in a 6 Hz test for the first 30 min of assessment and then disappeared, but reappeared after 4 h, however, at a lower level.…”
Section: Introductionmentioning
confidence: 93%
“…Our research team achieved satisfying results in terms of design and synthesis of new compounds for antidepressant‐like, anticonvulsant and anxiolytic‐like activity in a group of phenoxyalkyl and phenoxyethoxyethyl derivatives of piperazine (particularly N ‐(2‐methoxyphenyl)piperazine), as well as derivatives of aminoalkanols . In case of piperazine derivatives our preliminary research has focused on the potential antidepressant‐like activity of new compounds, their potential anxiolytic‐like or anticonvulsant activities were usually tested only for selected compounds.…”
Section: Introductionmentioning
confidence: 99%